Literature DB >> 10533796

Cerebral proton and phosphorus-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy.

S D Taylor-Robinson1, C Buckley, K K Changani, H J Hodgson, J D Bell.   

Abstract

BACKGROUND/AIMS: In vivo magnetic resonance spectroscopy can be used to study cerebral metabolism non-invasively. We aimed to correlate 1H and 31P magnetic resonance spectral abnormalities in the brains of patients with subclinical hepatic encephalopathy.
METHODS: Eighteen patients were studied at 1.5T, with combined 1H and 31P magnetic resonance spectra obtained from multiple voxels in the cerebral cortex and basal ganglia. Peak area ratios of choline, glutamine/glutamate, relative to creatine in the 1H spectra and percentage phosphomonoesters, phosphodiesters and betaNTP signals relative to total 31P signals in the 31P spectra were measured.
RESULTS: Six patients did not complete the full examination - 31P results are available from 12 patients only. Relative to creatine, there were reductions in choline and elevations in glutamine/glutamate, varying across the brain with choline significantly reduced in occipital cortex (p<0.05) and glutamine/glutamate most significantly elevated in temporo-parietal cortex (p<0.0001). Percentage phosphomonoester (p<0.05), phosphodiester (p<0.05) and betaNTP (p<0.005) signals were significantly decreased in basal ganglia spectra. No correlation was found between the magnitude of 1H and 31P MRS changes, except between percentage phosphodiester decrease and glutamine/glutamate to creatine increase in occipital cortex.
CONCLUSION: The results of this study point to a multifactorial aetiology for this condition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10533796     DOI: 10.1111/j.1478-3231.1999.tb00067.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  19 in total

Review 1.  Clinical significance of basal ganglia alterations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encephalopathy.

Authors:  Laurent Spahr; Pierre R Burkhard; Hannelore Grötzsch; Antoine Hadengue
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

2.  Role of Magnetic Resonance in Understanding the Pathogenesis of Hepatic Encephalopathy.

Authors:  A Huda; R K Gupta; N Rajakumar; M A Thomas
Journal:  Magn Reson Insights       Date:  2008

Review 3.  The role of magnetic resonance imaging and spectroscopy in hepatic encephalopathy.

Authors:  Mark J W McPhail; Simon D Taylor-Robinson
Journal:  Metab Brain Dis       Date:  2010-03-11       Impact factor: 3.584

Review 4.  Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview.

Authors:  Luigi Elio Adinolfi; Riccardo Nevola; Giacomo Lus; Luciano Restivo; Barbara Guerrera; Ciro Romano; Rosa Zampino; Luca Rinaldi; Ausilia Sellitto; Mauro Giordano; Aldo Marrone
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

5.  In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy.

Authors:  A Cagnin; S D Taylor-Robinson; D M Forton; R B Banati
Journal:  Gut       Date:  2005-10-06       Impact factor: 23.059

6.  Distinguishing between clinical and minimal hepatic encephalopathy on the basis of specific cognitive impairment.

Authors:  Katia Mattarozzi; Claudio Campi; Maria Guarino; Andrea Stracciari
Journal:  Metab Brain Dis       Date:  2005-09       Impact factor: 3.584

7.  Multi-dimensional MR spectroscopy: towards a better understanding of hepatic encephalopathy.

Authors:  Manoj K Sarma; Amir Huda; Rajakumar Nagarajan; Charles H Hinkin; Neil Wilson; Rakesh K Gupta; Enrique Frias-Martinez; James Sayre; Barry Guze; Steven-Huy Han; M Albert Thomas
Journal:  Metab Brain Dis       Date:  2011-06-23       Impact factor: 3.584

Review 8.  Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy.

Authors:  V-P Bob Grover; M-Alex Dresner; Daniel-M Forton; Serena Counsell; David-J Larkman; Nayna Patel; Howard-C Thomas; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

9.  1H and 31P magnetic resonance spectroscopy in a rat model of chronic hepatic encephalopathy: in vivo longitudinal measurements of brain energy metabolism.

Authors:  Veronika Rackayova; Olivier Braissant; Valérie A McLin; Corina Berset; Bernard Lanz; Cristina Cudalbu
Journal:  Metab Brain Dis       Date:  2015-08-09       Impact factor: 3.584

10.  Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels.

Authors:  D M Forton; N Patel; M Prince; A Oatridge; G Hamilton; J Goldblatt; J M Allsop; J V Hajnal; H C Thomas; M Bassendine; D E J Jones; S D Taylor-Robinson
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.